In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas

Olivier Manches, Gabrielle Lui, Laurence Chaperot, +7

Blood

Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells

Laurence Chaperot, Ariane Blum, Olivier Manches, +4

The Journal of Immunology

Tumor B Cells From Non-Hodgkin's Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis

Joël Plumas, Marie‐Christine Jacob, Laurence Chaperot, +3

Blood

TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN

Jérémy Di Domizio, Ariane Blum, Maighread Gallagher-Gambarelli, +3

Blood

Plasmacytoid Dendritic Cells Capture and Cross-Present Viral Antigens from Influenza-Virus Exposed Cells

Gabrielle Lui, Olivier Manches, Juliette Angel, +3

PLoS ONE

VaccinationMucosal VaccinationImmature PdcViral Infection PdcCross-present Viral Antigens +12

Imiquimod Inhibits Melanoma Development by Promoting pDC Cytotoxic Functions and Impeding Tumor Vascularization

Caroline Aspord, Laetitia Tramcourt, Jean‐Paul Molens, +3

Journal of Investigative Dermatology

Tumor BiologyCancer ImmunosurveillanceMelanomaImmunologyImpeding Tumor Vascularization +8

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin’s lymphomas

Laurence Chaperot, Joël Plumas, Marie‐Christine Jacob, +4

Experimental Hematology

Lymphoid NeoplasiaCancer ImmunosurveillanceMalignant B CellsFunctional ExpressionMalignant Blood Disorder +9

Malignant B lymphocytes from non‐Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: An important role of co‐stimulatory molecules CD80 (B7‐1) and CD86 (B7‐2) in stimulation by tumor cells

Joël Plumas, Laurence Chaperot, Marie‐Christine Jacob, +4

European Journal of Immunology

Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells

Juliette Angel, Laurence Chaperot, Jean‐Paul Molens, +5

Vaccine

ImmunologyTherapeutic VaccineTumor AntigenImmunotherapyMedicine +1

Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.

Olivier Manches, Joël Plumas, Gabrielle Lui, +5

PubMed